An hepatologist perspective Hepatitis C in Portugal · An hepatologist perspective Hepatitis C in...
Transcript of An hepatologist perspective Hepatitis C in Portugal · An hepatologist perspective Hepatitis C in...
![Page 1: An hepatologist perspective Hepatitis C in Portugal · An hepatologist perspective Hepatitis C in Portugal . Abbvie, Merck, BMS, Roche, Janssen, Bayer, Gilead Conflit of Interests](https://reader033.fdocuments.in/reader033/viewer/2022042116/5e93337534701e36b84af4a3/html5/thumbnails/1.jpg)
Gastroenterology and Hepatology
President of Hepatology of Portuguese Medical Board
Editor-in-Chief of Acta Médica Portuguesa
Vice-President Portuguese Society of Gastroenterology
President of Scientific Committe of SOS Hepatites (patient NGO)
Infarmed – Consultive panel for hepatitis C
Ministry of Health – National Strategy for hepatitis C
Elected Member of General Assembly of United European Gastroenterology,
Advisory Member of Viral Hepatitis Prevention Board (WHO, CDC, ELPA ECDC)
Rui Tato Marinho ([email protected])
An hepatologist perspective
Hepatitis C in Portugal
![Page 2: An hepatologist perspective Hepatitis C in Portugal · An hepatologist perspective Hepatitis C in Portugal . Abbvie, Merck, BMS, Roche, Janssen, Bayer, Gilead Conflit of Interests](https://reader033.fdocuments.in/reader033/viewer/2022042116/5e93337534701e36b84af4a3/html5/thumbnails/2.jpg)
Abbvie, Merck, BMS, Roche, Janssen, Bayer, Gilead
Conflit of Interests - 1 and 2
President of Hepatology of Portuguese Medical Board
Editor-in-Chief of Acta Médica Portuguesa
Vice-President Portuguese Society of Gastroenterology
President of Scientific Committe of SOS Hepatites (patient NGO)
Infarmed (portuguese FDA) – Consultive panel for hepatitis C
Ministry of Health – National Strategy for hepatitis C
Elected Member of General Assembly of United European Gastroenterology,
Advisory Member of Viral Hepatitis Prevention Board (WHO, CDC, ELPA ECDC)
![Page 3: An hepatologist perspective Hepatitis C in Portugal · An hepatologist perspective Hepatitis C in Portugal . Abbvie, Merck, BMS, Roche, Janssen, Bayer, Gilead Conflit of Interests](https://reader033.fdocuments.in/reader033/viewer/2022042116/5e93337534701e36b84af4a3/html5/thumbnails/3.jpg)
We have a big problem!!
portugueses with hepatitis C
![Page 4: An hepatologist perspective Hepatitis C in Portugal · An hepatologist perspective Hepatitis C in Portugal . Abbvie, Merck, BMS, Roche, Janssen, Bayer, Gilead Conflit of Interests](https://reader033.fdocuments.in/reader033/viewer/2022042116/5e93337534701e36b84af4a3/html5/thumbnails/4.jpg)
4 key ideas hepatitis C
Cirrhosis
risk of Cancer
risk of death
Cure
![Page 5: An hepatologist perspective Hepatitis C in Portugal · An hepatologist perspective Hepatitis C in Portugal . Abbvie, Merck, BMS, Roche, Janssen, Bayer, Gilead Conflit of Interests](https://reader033.fdocuments.in/reader033/viewer/2022042116/5e93337534701e36b84af4a3/html5/thumbnails/5.jpg)
![Page 6: An hepatologist perspective Hepatitis C in Portugal · An hepatologist perspective Hepatitis C in Portugal . Abbvie, Merck, BMS, Roche, Janssen, Bayer, Gilead Conflit of Interests](https://reader033.fdocuments.in/reader033/viewer/2022042116/5e93337534701e36b84af4a3/html5/thumbnails/6.jpg)
“Core business”
Liver Cirrhosis
Hepatitis C, B, alcohol, obesity
30-40%
![Page 7: An hepatologist perspective Hepatitis C in Portugal · An hepatologist perspective Hepatitis C in Portugal . Abbvie, Merck, BMS, Roche, Janssen, Bayer, Gilead Conflit of Interests](https://reader033.fdocuments.in/reader033/viewer/2022042116/5e93337534701e36b84af4a3/html5/thumbnails/7.jpg)
Cirrhosis 40%
Cancer 1-4% each year
![Page 8: An hepatologist perspective Hepatitis C in Portugal · An hepatologist perspective Hepatitis C in Portugal . Abbvie, Merck, BMS, Roche, Janssen, Bayer, Gilead Conflit of Interests](https://reader033.fdocuments.in/reader033/viewer/2022042116/5e93337534701e36b84af4a3/html5/thumbnails/8.jpg)
Chiaramonte et al, Cancer 1999;85:2132-7
Rate of incidence of HCC in patients with
compensated viral cirrhosis
n=66
n=166
n=27
![Page 9: An hepatologist perspective Hepatitis C in Portugal · An hepatologist perspective Hepatitis C in Portugal . Abbvie, Merck, BMS, Roche, Janssen, Bayer, Gilead Conflit of Interests](https://reader033.fdocuments.in/reader033/viewer/2022042116/5e93337534701e36b84af4a3/html5/thumbnails/9.jpg)
Esteban JI, Sauleda S, Quer J. The changing epidemiology of hepatitis C virus infection in Europe. J Hepatol 2008;48:148-62.
Prevalence of Hepatitis C in Europe
![Page 10: An hepatologist perspective Hepatitis C in Portugal · An hepatologist perspective Hepatitis C in Portugal . Abbvie, Merck, BMS, Roche, Janssen, Bayer, Gilead Conflit of Interests](https://reader033.fdocuments.in/reader033/viewer/2022042116/5e93337534701e36b84af4a3/html5/thumbnails/10.jpg)
PWID 100 000 (60%) > 60 000
HIV 40 000 (25-30%) > 12 000
Transfusions, sexual, health care workers
30% no risk factor
HCV in Portugal ~1%?
![Page 11: An hepatologist perspective Hepatitis C in Portugal · An hepatologist perspective Hepatitis C in Portugal . Abbvie, Merck, BMS, Roche, Janssen, Bayer, Gilead Conflit of Interests](https://reader033.fdocuments.in/reader033/viewer/2022042116/5e93337534701e36b84af4a3/html5/thumbnails/11.jpg)
Dying
HCV
![Page 12: An hepatologist perspective Hepatitis C in Portugal · An hepatologist perspective Hepatitis C in Portugal . Abbvie, Merck, BMS, Roche, Janssen, Bayer, Gilead Conflit of Interests](https://reader033.fdocuments.in/reader033/viewer/2022042116/5e93337534701e36b84af4a3/html5/thumbnails/12.jpg)
HCV-related death rates in countries of
the WHO European region in 2002
Mühlberger N, et al. BMC Public Health 2009;9:34
≤6 6–9 9–12 >12 Death rate
(deaths per 100,000):
HCV ~1000
HIV 561 (2012)
![Page 13: An hepatologist perspective Hepatitis C in Portugal · An hepatologist perspective Hepatitis C in Portugal . Abbvie, Merck, BMS, Roche, Janssen, Bayer, Gilead Conflit of Interests](https://reader033.fdocuments.in/reader033/viewer/2022042116/5e93337534701e36b84af4a3/html5/thumbnails/13.jpg)
![Page 14: An hepatologist perspective Hepatitis C in Portugal · An hepatologist perspective Hepatitis C in Portugal . Abbvie, Merck, BMS, Roche, Janssen, Bayer, Gilead Conflit of Interests](https://reader033.fdocuments.in/reader033/viewer/2022042116/5e93337534701e36b84af4a3/html5/thumbnails/14.jpg)
![Page 15: An hepatologist perspective Hepatitis C in Portugal · An hepatologist perspective Hepatitis C in Portugal . Abbvie, Merck, BMS, Roche, Janssen, Bayer, Gilead Conflit of Interests](https://reader033.fdocuments.in/reader033/viewer/2022042116/5e93337534701e36b84af4a3/html5/thumbnails/15.jpg)
53 62
Needing treatment Dying
![Page 16: An hepatologist perspective Hepatitis C in Portugal · An hepatologist perspective Hepatitis C in Portugal . Abbvie, Merck, BMS, Roche, Janssen, Bayer, Gilead Conflit of Interests](https://reader033.fdocuments.in/reader033/viewer/2022042116/5e93337534701e36b84af4a3/html5/thumbnails/16.jpg)
Inquiry to State Hospitals
13 000 in outpatient consultations
~5 000 with cirrhosis
![Page 17: An hepatologist perspective Hepatitis C in Portugal · An hepatologist perspective Hepatitis C in Portugal . Abbvie, Merck, BMS, Roche, Janssen, Bayer, Gilead Conflit of Interests](https://reader033.fdocuments.in/reader033/viewer/2022042116/5e93337534701e36b84af4a3/html5/thumbnails/17.jpg)
Hot Topic
![Page 18: An hepatologist perspective Hepatitis C in Portugal · An hepatologist perspective Hepatitis C in Portugal . Abbvie, Merck, BMS, Roche, Janssen, Bayer, Gilead Conflit of Interests](https://reader033.fdocuments.in/reader033/viewer/2022042116/5e93337534701e36b84af4a3/html5/thumbnails/18.jpg)
![Page 19: An hepatologist perspective Hepatitis C in Portugal · An hepatologist perspective Hepatitis C in Portugal . Abbvie, Merck, BMS, Roche, Janssen, Bayer, Gilead Conflit of Interests](https://reader033.fdocuments.in/reader033/viewer/2022042116/5e93337534701e36b84af4a3/html5/thumbnails/19.jpg)
Landmarks – Cure hepatitis C (genotype 1)
Hepatitis C, stigma and cure. Marinho RT, Barreira D, World Journal Gastroenterology 2013
1986 1995 2000 2011 2013/2014
![Page 20: An hepatologist perspective Hepatitis C in Portugal · An hepatologist perspective Hepatitis C in Portugal . Abbvie, Merck, BMS, Roche, Janssen, Bayer, Gilead Conflit of Interests](https://reader033.fdocuments.in/reader033/viewer/2022042116/5e93337534701e36b84af4a3/html5/thumbnails/20.jpg)
![Page 21: An hepatologist perspective Hepatitis C in Portugal · An hepatologist perspective Hepatitis C in Portugal . Abbvie, Merck, BMS, Roche, Janssen, Bayer, Gilead Conflit of Interests](https://reader033.fdocuments.in/reader033/viewer/2022042116/5e93337534701e36b84af4a3/html5/thumbnails/21.jpg)
Only now?
![Page 22: An hepatologist perspective Hepatitis C in Portugal · An hepatologist perspective Hepatitis C in Portugal . Abbvie, Merck, BMS, Roche, Janssen, Bayer, Gilead Conflit of Interests](https://reader033.fdocuments.in/reader033/viewer/2022042116/5e93337534701e36b84af4a3/html5/thumbnails/22.jpg)
![Page 23: An hepatologist perspective Hepatitis C in Portugal · An hepatologist perspective Hepatitis C in Portugal . Abbvie, Merck, BMS, Roche, Janssen, Bayer, Gilead Conflit of Interests](https://reader033.fdocuments.in/reader033/viewer/2022042116/5e93337534701e36b84af4a3/html5/thumbnails/23.jpg)
2014 1989 1997
WHO Call Attention!
![Page 24: An hepatologist perspective Hepatitis C in Portugal · An hepatologist perspective Hepatitis C in Portugal . Abbvie, Merck, BMS, Roche, Janssen, Bayer, Gilead Conflit of Interests](https://reader033.fdocuments.in/reader033/viewer/2022042116/5e93337534701e36b84af4a3/html5/thumbnails/24.jpg)
Hepatitis C in media (1997)
![Page 26: An hepatologist perspective Hepatitis C in Portugal · An hepatologist perspective Hepatitis C in Portugal . Abbvie, Merck, BMS, Roche, Janssen, Bayer, Gilead Conflit of Interests](https://reader033.fdocuments.in/reader033/viewer/2022042116/5e93337534701e36b84af4a3/html5/thumbnails/26.jpg)
Plano Nacional para a Hepatite C. Revista Ordem dos Médicos 2005:53:28-30
2005
![Page 27: An hepatologist perspective Hepatitis C in Portugal · An hepatologist perspective Hepatitis C in Portugal . Abbvie, Merck, BMS, Roche, Janssen, Bayer, Gilead Conflit of Interests](https://reader033.fdocuments.in/reader033/viewer/2022042116/5e93337534701e36b84af4a3/html5/thumbnails/27.jpg)
Hepatocellular
carcinoma
![Page 29: An hepatologist perspective Hepatitis C in Portugal · An hepatologist perspective Hepatitis C in Portugal . Abbvie, Merck, BMS, Roche, Janssen, Bayer, Gilead Conflit of Interests](https://reader033.fdocuments.in/reader033/viewer/2022042116/5e93337534701e36b84af4a3/html5/thumbnails/29.jpg)
http://www.vhpb.org/
Hepatitis C 2010
![Page 30: An hepatologist perspective Hepatitis C in Portugal · An hepatologist perspective Hepatitis C in Portugal . Abbvie, Merck, BMS, Roche, Janssen, Bayer, Gilead Conflit of Interests](https://reader033.fdocuments.in/reader033/viewer/2022042116/5e93337534701e36b84af4a3/html5/thumbnails/30.jpg)
The normal
![Page 31: An hepatologist perspective Hepatitis C in Portugal · An hepatologist perspective Hepatitis C in Portugal . Abbvie, Merck, BMS, Roche, Janssen, Bayer, Gilead Conflit of Interests](https://reader033.fdocuments.in/reader033/viewer/2022042116/5e93337534701e36b84af4a3/html5/thumbnails/31.jpg)
![Page 32: An hepatologist perspective Hepatitis C in Portugal · An hepatologist perspective Hepatitis C in Portugal . Abbvie, Merck, BMS, Roche, Janssen, Bayer, Gilead Conflit of Interests](https://reader033.fdocuments.in/reader033/viewer/2022042116/5e93337534701e36b84af4a3/html5/thumbnails/32.jpg)
![Page 33: An hepatologist perspective Hepatitis C in Portugal · An hepatologist perspective Hepatitis C in Portugal . Abbvie, Merck, BMS, Roche, Janssen, Bayer, Gilead Conflit of Interests](https://reader033.fdocuments.in/reader033/viewer/2022042116/5e93337534701e36b84af4a3/html5/thumbnails/33.jpg)
RM
NR
N 130
2011
No response
cure
![Page 34: An hepatologist perspective Hepatitis C in Portugal · An hepatologist perspective Hepatitis C in Portugal . Abbvie, Merck, BMS, Roche, Janssen, Bayer, Gilead Conflit of Interests](https://reader033.fdocuments.in/reader033/viewer/2022042116/5e93337534701e36b84af4a3/html5/thumbnails/34.jpg)
Triple
Double
Oral
![Page 35: An hepatologist perspective Hepatitis C in Portugal · An hepatologist perspective Hepatitis C in Portugal . Abbvie, Merck, BMS, Roche, Janssen, Bayer, Gilead Conflit of Interests](https://reader033.fdocuments.in/reader033/viewer/2022042116/5e93337534701e36b84af4a3/html5/thumbnails/35.jpg)
Peginterferon
weekly
24 or 48 weeks
+ Ribavirine
daily
Double treatment
![Page 36: An hepatologist perspective Hepatitis C in Portugal · An hepatologist perspective Hepatitis C in Portugal . Abbvie, Merck, BMS, Roche, Janssen, Bayer, Gilead Conflit of Interests](https://reader033.fdocuments.in/reader033/viewer/2022042116/5e93337534701e36b84af4a3/html5/thumbnails/36.jpg)
4 8/8h day (48w) 3 12/12 day (12w)
4032/6500- pills, 1008 times Boceprevir
504 pills, 168 times Telaprevir
![Page 37: An hepatologist perspective Hepatitis C in Portugal · An hepatologist perspective Hepatitis C in Portugal . Abbvie, Merck, BMS, Roche, Janssen, Bayer, Gilead Conflit of Interests](https://reader033.fdocuments.in/reader033/viewer/2022042116/5e93337534701e36b84af4a3/html5/thumbnails/37.jpg)
Boceprevir Telaprevir
8 000
40m
200
10m
2011 - 2013
![Page 38: An hepatologist perspective Hepatitis C in Portugal · An hepatologist perspective Hepatitis C in Portugal . Abbvie, Merck, BMS, Roche, Janssen, Bayer, Gilead Conflit of Interests](https://reader033.fdocuments.in/reader033/viewer/2022042116/5e93337534701e36b84af4a3/html5/thumbnails/38.jpg)
Oral
DAA
![Page 39: An hepatologist perspective Hepatitis C in Portugal · An hepatologist perspective Hepatitis C in Portugal . Abbvie, Merck, BMS, Roche, Janssen, Bayer, Gilead Conflit of Interests](https://reader033.fdocuments.in/reader033/viewer/2022042116/5e93337534701e36b84af4a3/html5/thumbnails/39.jpg)
Approved
![Page 40: An hepatologist perspective Hepatitis C in Portugal · An hepatologist perspective Hepatitis C in Portugal . Abbvie, Merck, BMS, Roche, Janssen, Bayer, Gilead Conflit of Interests](https://reader033.fdocuments.in/reader033/viewer/2022042116/5e93337534701e36b84af4a3/html5/thumbnails/40.jpg)
![Page 41: An hepatologist perspective Hepatitis C in Portugal · An hepatologist perspective Hepatitis C in Portugal . Abbvie, Merck, BMS, Roche, Janssen, Bayer, Gilead Conflit of Interests](https://reader033.fdocuments.in/reader033/viewer/2022042116/5e93337534701e36b84af4a3/html5/thumbnails/41.jpg)
36 papers NEJM in 3 years
![Page 42: An hepatologist perspective Hepatitis C in Portugal · An hepatologist perspective Hepatitis C in Portugal . Abbvie, Merck, BMS, Roche, Janssen, Bayer, Gilead Conflit of Interests](https://reader033.fdocuments.in/reader033/viewer/2022042116/5e93337534701e36b84af4a3/html5/thumbnails/42.jpg)
H. Santa Maria 16 patients cure 100% Portugal 40 patients cure 100%
![Page 43: An hepatologist perspective Hepatitis C in Portugal · An hepatologist perspective Hepatitis C in Portugal . Abbvie, Merck, BMS, Roche, Janssen, Bayer, Gilead Conflit of Interests](https://reader033.fdocuments.in/reader033/viewer/2022042116/5e93337534701e36b84af4a3/html5/thumbnails/43.jpg)
New era
DAAs Oral
Three (two) months of treatment
No side effects
Cure >90%
€€€€€€€€€€.££££££££.USD.USD.USD
![Page 44: An hepatologist perspective Hepatitis C in Portugal · An hepatologist perspective Hepatitis C in Portugal . Abbvie, Merck, BMS, Roche, Janssen, Bayer, Gilead Conflit of Interests](https://reader033.fdocuments.in/reader033/viewer/2022042116/5e93337534701e36b84af4a3/html5/thumbnails/44.jpg)
![Page 45: An hepatologist perspective Hepatitis C in Portugal · An hepatologist perspective Hepatitis C in Portugal . Abbvie, Merck, BMS, Roche, Janssen, Bayer, Gilead Conflit of Interests](https://reader033.fdocuments.in/reader033/viewer/2022042116/5e93337534701e36b84af4a3/html5/thumbnails/45.jpg)
![Page 46: An hepatologist perspective Hepatitis C in Portugal · An hepatologist perspective Hepatitis C in Portugal . Abbvie, Merck, BMS, Roche, Janssen, Bayer, Gilead Conflit of Interests](https://reader033.fdocuments.in/reader033/viewer/2022042116/5e93337534701e36b84af4a3/html5/thumbnails/46.jpg)
Peginterferon
Treatment Hepatite C
Biopsy
![Page 47: An hepatologist perspective Hepatitis C in Portugal · An hepatologist perspective Hepatitis C in Portugal . Abbvie, Merck, BMS, Roche, Janssen, Bayer, Gilead Conflit of Interests](https://reader033.fdocuments.in/reader033/viewer/2022042116/5e93337534701e36b84af4a3/html5/thumbnails/47.jpg)
Sofosbuvir
Simeprevir
Daclatasvir
Sofosbuvir + Ledipasvir (((Abbvie, Merck)))
![Page 48: An hepatologist perspective Hepatitis C in Portugal · An hepatologist perspective Hepatitis C in Portugal . Abbvie, Merck, BMS, Roche, Janssen, Bayer, Gilead Conflit of Interests](https://reader033.fdocuments.in/reader033/viewer/2022042116/5e93337534701e36b84af4a3/html5/thumbnails/48.jpg)
Sofosbuvir
80 000 (USA)
15 000 (16 european countries)
7 (Portugal)
![Page 49: An hepatologist perspective Hepatitis C in Portugal · An hepatologist perspective Hepatitis C in Portugal . Abbvie, Merck, BMS, Roche, Janssen, Bayer, Gilead Conflit of Interests](https://reader033.fdocuments.in/reader033/viewer/2022042116/5e93337534701e36b84af4a3/html5/thumbnails/49.jpg)
Reduce Risk of Death
• Screen with anti-HCV
• Fibroscan
• Treat and cure
![Page 50: An hepatologist perspective Hepatitis C in Portugal · An hepatologist perspective Hepatitis C in Portugal . Abbvie, Merck, BMS, Roche, Janssen, Bayer, Gilead Conflit of Interests](https://reader033.fdocuments.in/reader033/viewer/2022042116/5e93337534701e36b84af4a3/html5/thumbnails/50.jpg)
Reduce Risk of Death
• Screen with anti-HCV
• Fibroscan
• Treat and cure for ever
![Page 51: An hepatologist perspective Hepatitis C in Portugal · An hepatologist perspective Hepatitis C in Portugal . Abbvie, Merck, BMS, Roche, Janssen, Bayer, Gilead Conflit of Interests](https://reader033.fdocuments.in/reader033/viewer/2022042116/5e93337534701e36b84af4a3/html5/thumbnails/51.jpg)
No response
Sustained response cure)